BioMetry acquires Telcare for $7M


For me this acquisition highlights how incredible challenging it can be to make a success with even the most brilliant mHealth device innovation.

To put things in context consider how Nest put WiFi in beautifully designed smoke alarms and thermostats that sold through the Apple retail stores and even though the tech turned out to be rather sketchy the company grew to a 110 strong team before being acquired by Google for $3.2B, and compare that with how Telcare managed the far more technically challenging task of embedding Mobile network connectivity into FDA Cleared and CE marked Glucometers before convincing insurers and healthcare organisations to buy these and train their staff and supply strips through pharmacies yet only managed to sell for $7M (even though the company had raised more than $60M from leading VC funds such as Sequoia Capital and Qualcomm Life).

In 2013 I was given a contract to get Telcare sales started in Europe and while I got the go ahead for a trial in a leading hospital the experience was a huge learning curve for me. One particularly memorable insight was when a NHS Consultant Endocrinologist who really wanted to give Telcare Glucometers to Patients of his with Gestational Diabetes (good blood glucose control in pregnancy greatly reduces likelihood of adverse pregnancy outcomes, miscarriages, macrosomia, operative births, pre-eclampsia, premature births, neonatal ICU admissions, etc) told me he could sooner get his hospital to build him a brand new state of the art surgical ward to treat Patients with Diabetes than he could have them buy a single Telcare Glucometer…

Why Big Pharma struggles to innovate with mHealth

Let’s hope BioMetry (formerly Cardionet) can make a success with the innovative Telcare tech and team.

Related Posts:

An interview with David Doherty on how the IoT will impact on Healthcare

The International Diabetes Federation calls for mHealth to become an embedded compulsory part of how we provide quality care for diabetics.

Watch the CPD accredited mHealth Symposium that I delivered at the World Diabetes Congress in Vancouver (the world’s biggest Diabetes industry meeting).

About David Doherty
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s